External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ESH-LYMPHOID 2023

-
Coming soon
05:40 PM
Duration 60mins Estoril, Portugal
Pharmacodynamic effects of glofitamab▼ administration in frontline diffuse large B-cell lymphoma patients following R-CHOP chemotherapy
Pontus Lundberg

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Estoril, Portugal
A multifactorial analysis of structural relationships between clinical variables and biomarkers to explain their influence on glofitamab▼ response in patients with R/R LBCL
Anton Belousov

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar